
ZBIO Investor Reminder: Cohen Milstein Encourages Zenas BioPharma Investors to Consider Leading Class Action Following ...
WASHINGTON, April 29, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC, a nationally prominent securities litigation firm, announces that retail and institutional investors who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) …